IP Library Granted Patent US 10,457,932
Granted Patent B2
US 10,457,932 · App. 15/639,401 · Granted Oct 29, 2019

Methods for in vitro ribosome synthesis and evolution

Inventors: Michael Christopher Jewett (Evanston, IL); Brian R. Fritz (Chicago, IL)
Assignee: Northwestern University
C12N15/1058C12N15/1041C40B30/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,457,932
App. No.
15/639,401
Granted
Oct 29, 2019
Kind
B2
Abstract

Disclosed are methods, components, compositions, and kits for preparing and identifying engineered E. coli ribosomes. The E. coli ribosomes may be prepared and identified under a set of defined conditions, such as in the presences of antibiotics, in order to obtain an engineered ribosome that is resistant to the antibiotic.

Claims (23)

1. A method of identifying an engineered or modified E. coli ribosome having functional activity under a defined condition, comprising:

(a) performing an integrated ribosome synthesis assembly and translation (iSAT) reaction with a library of mutated rRNA templates and a ribosome display reporter template; and

(b) partitioning a subpopulation of rRNAs in assembled mutated ribosomes having translational activity under the defined condition from a remainder population of mutated rRNAs present in the iSAT reaction; and

(c) enriching the partitioned subpopulation of rRNAs in assembled mutated ribosomes having translational activity to identify the engineered E. coli ribosome having functional activity under the defined condition.

2. The method of claim 1 , further comprising generating the library of mutated rRNA templates.

3. The method of claim 2 , wherein the library of mutated rRNA templates is generated by a method that includes a step selected from the group consisting of DNA shuffling, error-prone DNA amplification, degenerate primer-based DNA amplification, and specific modifications based on crystal structure guided rational targeting.

4. The method of claim 1 , wherein the ribosome display reporter template comprises a reporter gene operably linked to a 5′-promoter element, a 3′-spacer element, and a 3′-self-cleaving ribozyme element.

5. The method of claim 4 , wherein the reporter gene comprises or encodes a binding partner.

6. The method of claim 5 , wherein the partitioning step (b) comprises:

(i) forming a ternary complex comprising a stalled ribosome on a mRNA terminated by a self-cleaving ribozyme in the presence of an anti-ssrA oligonucleotide; and

(ii) selecting the ternary complex with a cognate binding partner to the binding partner of the reporter gene to form a quaternary complex comprising the ternary complex associated with the cognate binding partner.

7. The method of claim 6 , wherein the cognate binding partner comprises a capture reagent.

8. The method of claim 6 , wherein the binding partner comprises a peptide tag.

9. The method of claim 8 , wherein the peptide tag is selected from a group consisting of FLAG-tag, 3×FLAG-tag, His-tag, Strep-tag, and glutathione S-transferase.

10. The method of claim 9 , further comprising washing the selected quaternary complex under a defined stringency condition.

11. The method of claim 1 , wherein the enriching step (c) comprises:

(i) recovering the subpopulation of rRNAs in assembled mutated ribosomes having translational activity;

(ii) converting the subpopulation of rRNAs to form a plurality of rRNA templates; and

(iii) amplifying the plurality of rRNA templates.

12. The method of claim 1 , wherein the defined condition is selected from the group consisting of defined temperature, defined pH, a redox environment, or the presence of one or more additives.

13. The method of claim 12 , wherein the one or more additives comprise an antibiotic.

14. The method of claim 1 , further comprising executing steps (a)-(c) in a reiterative manner.

15. A method of identifying an engineered or modified E. coli ribosome having functional activity in the presence of an antibiotic, the method comprising performing the method of claim 1 in the presence of the antibiotic.

Assignments (2)
GOVERNMENT INTEREST AGREEMENT Recorded Mar 17, 2025
From: NORTHWESTERN UNIVERSITY
To: THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY
Reel/Frame 070531/0522 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 2, 2017
From: JEWETT, MICHAEL CHRISTOPHER; FRITZ, BRIAN ROBERT
To: NORTHWESTERN UNIVERSITY
Reel/Frame 043169/0030 →
Continuity (3)
Continuation In Part PCTIB2015059964 · Dec 23, 2015
Provisional Application 62098622 · Dec 31, 2014
Related Publication 20170306320A1 · Oct 26, 2017
Cited By (2)
US 12,421,537 US 12,624,375